All Michael Silverman articles
-
NewsWorld first clinical trial will study specialized ‘poop pills’ to improve treatment of advanced pancreatic cancer
A world-pioneering fecal microbiota transplantation pill will undergo a clinical trial, aiming to improve immune responses by remodifying the gut microbiome in patients with advance pancreatic cancer.
-
NewsResearchers discover new bacterium that causes gut immunodeficiency
The new findings lay the groundwork for potential new treatments for variety of inflammatory and infectious diseases including inflammatory bowel disease, Crohn’s and ulcerative colitis.